诺和诺德Amycretin二期临床报告称该药可减轻体重,减少2型糖尿病风险

老虎资讯综合
Nov 25, 2025

诺和诺德的Amycretin二期临床试验报告称,该药物可带来体重减轻并减少2型糖尿病风险。受试者在36周时显示出高达14.5%的体重减轻效果。

诺和诺德 盘前拉升,一度涨超2%。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10